Can I read Joint TITE-CRM for Dual Agent Dose Finding Studies on EtoBox?

Joint TITE-CRM for Dual Agent Dose Finding Studies by Barnett, Helen; Boix, Oliver; Kontos, Dimitris; Jaki, Thomas is a scholarly article available to read on EtoBox.

What is Joint TITE-CRM for Dual Agent Dose Finding Studies about?

Dual agent dose-finding trials study the effect of a combination of more than one agent, where the objective is to find the Maximum Tolerated Dose Combination (MTC), the combination of doses of the two agents that is associated with a pre-specified risk of being unsafe. In a Phase I/II setting, the objective is to find a dose combination that is both safe and active, the Optimal Biological Dose (OBD), that optimizes a criterion based on both safety and activity. Since Oncology treatments are typically given over multiple cycles, both the safety and activity outcome can be considered as late-onset, potentially occurring in the later cycles of treatment. This work proposes two model-based designs for dual-agent dose finding studies with late-onset activity and late-onset toxicity outcomes, the Joint TITE-POCRM and the Joint TITE-BLRM. Their performance is compared alongside a model-assisted comparator in a comprehensive simulation study motivated by a real trial example, with an extension to consider alternative sized dosing grids. It is found that both model-based methods outperform the model-assisted design. Whilst on average the two model-based designs are comparable, this compara

Author

Barnett, Helen; Boix, Oliver; Kontos, Dimitris; Jaki, Thomas

Published

2025

Language

EN